ICU Medical ROE 2012-2025 | ICUI
Current and historical return on equity (ROE) values for ICU Medical (ICUI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ICU Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.01B | $2.13B | -0.34% |
| 2025-06-30 | $-0.04B | $2.12B | -1.82% |
| 2025-03-31 | $-0.09B | $1.99B | -4.63% |
| 2024-12-31 | $-0.12B | $1.97B | -5.76% |
| 2024-09-30 | $-0.11B | $2.05B | -5.32% |
| 2024-06-30 | $-0.07B | $2.04B | -3.36% |
| 2024-03-31 | $-0.06B | $2.07B | -2.81% |
| 2023-12-31 | $-0.03B | $2.12B | -1.42% |
| 2023-09-30 | $-0.03B | $2.10B | -1.38% |
| 2023-06-30 | $-0.05B | $2.12B | -2.36% |
| 2023-03-31 | $-0.05B | $2.10B | -2.22% |
| 2022-12-31 | $-0.07B | $2.09B | -3.54% |
| 2022-09-30 | $-0.04B | $2.01B | -1.93% |
| 2022-06-30 | $0.01B | $2.09B | 0.32% |
| 2022-03-31 | $0.04B | $2.18B | 2.36% |
| 2021-12-31 | $0.10B | $1.62B | 6.56% |
| 2021-09-30 | $0.11B | $1.59B | 7.07% |
| 2021-06-30 | $0.10B | $1.56B | 6.83% |
| 2021-03-31 | $0.09B | $1.52B | 6.39% |
| 2020-12-31 | $0.09B | $1.50B | 6.06% |
| 2020-09-30 | $0.08B | $1.45B | 5.84% |
| 2020-06-30 | $0.08B | $1.41B | 6.10% |
| 2020-03-31 | $0.09B | $1.38B | 6.51% |
| 2019-12-31 | $0.10B | $1.38B | 7.67% |
| 2019-09-30 | $0.07B | $1.34B | 5.69% |
| 2019-06-30 | $0.05B | $1.32B | 3.67% |
| 2019-03-31 | $0.06B | $1.28B | 4.34% |
| 2018-12-31 | $0.03B | $1.26B | 2.31% |
| 2018-09-30 | $0.09B | $1.26B | 6.96% |
| 2018-06-30 | $0.09B | $1.26B | 7.13% |
| 2018-03-31 | $0.02B | $1.23B | 1.53% |
| 2017-12-31 | $0.07B | $1.20B | 6.00% |
| 2017-09-30 | $0.03B | $1.14B | 2.85% |
| 2017-06-30 | $0.05B | $1.12B | 5.38% |
| 2017-03-31 | $0.10B | $1.14B | 13.31% |
| 2016-12-31 | $0.06B | $0.66B | 10.16% |
| 2016-09-30 | $0.06B | $0.65B | 9.67% |
| 2016-06-30 | $0.06B | $0.62B | 9.50% |
| 2016-03-31 | $0.05B | $0.60B | 9.29% |
| 2015-12-31 | $0.05B | $0.58B | 8.17% |
| 2015-09-30 | $0.05B | $0.57B | 8.82% |
| 2015-06-30 | $0.04B | $0.54B | 7.20% |
| 2015-03-31 | $0.03B | $0.52B | 5.79% |
| 2014-12-31 | $0.03B | $0.51B | 5.31% |
| 2014-09-30 | $0.03B | $0.49B | 6.68% |
| 2014-06-30 | $0.04B | $0.49B | 7.97% |
| 2014-03-31 | $0.04B | $0.47B | 8.51% |
| 2013-12-31 | $0.04B | $0.47B | 9.32% |
| 2013-09-30 | $0.04B | $0.43B | 9.50% |
| 2013-06-30 | $0.04B | $0.42B | 10.11% |
| 2013-03-31 | $0.04B | $0.40B | 11.06% |
| 2012-12-31 | $0.04B | $0.39B | 11.26% |
| 2012-09-30 | $0.05B | $0.37B | 13.56% |
| 2012-06-30 | $0.04B | $0.35B | 13.33% |
| 2012-03-31 | $0.04B | $0.34B | 13.80% |
| 2011-12-31 | $0.04B | $0.32B | 14.38% |
| 2011-09-30 | $0.04B | $0.31B | 11.91% |
| 2011-06-30 | $0.04B | $0.31B | 12.39% |
| 2011-03-31 | $0.03B | $0.29B | 12.73% |
| 2010-12-31 | $0.03B | $0.27B | 11.72% |
| 2010-09-30 | $0.03B | $0.26B | 10.62% |
| 2010-06-30 | $0.02B | $0.25B | 9.30% |
| 2010-03-31 | $0.02B | $0.25B | 8.34% |
| 2009-12-31 | $0.03B | $0.27B | 9.34% |
| 2009-09-30 | $0.03B | $0.28B | 10.58% |
| 2009-06-30 | $0.03B | $0.27B | 11.74% |
| 2009-03-31 | $0.03B | $0.26B | 11.78% |
| 2008-12-31 | $0.03B | $0.25B | 10.59% |
| 2008-09-30 | $0.02B | $0.24B | 9.72% |
| 2008-06-30 | $0.02B | $0.23B | 8.58% |
| 2008-03-31 | $0.02B | $0.22B | 7.67% |
| 2007-12-31 | $0.02B | $0.21B | 10.74% |
| 2007-09-30 | $0.03B | $0.22B | 11.05% |
| 2007-06-30 | $0.03B | $0.23B | 11.53% |
| 2007-03-31 | $0.03B | $0.23B | 13.17% |
| 2006-12-31 | $0.03B | $0.23B | 11.74% |
| 2006-09-30 | $0.02B | $0.22B | 11.27% |
| 2006-06-30 | $0.02B | $0.21B | 11.87% |
| 2006-03-31 | $0.02B | $0.20B | 11.96% |
| 2005-12-31 | $0.02B | $0.19B | 11.43% |
| 2005-09-30 | $0.01B | $0.18B | 7.80% |
| 2005-06-30 | $0.01B | $0.17B | 3.71% |
| 2005-03-31 | $0.00B | $0.16B | 2.48% |
| 2004-12-31 | $0.00B | $0.16B | 2.49% |
| 2004-09-30 | $0.01B | $0.16B | 8.10% |
| 2004-06-30 | $0.02B | $0.17B | 11.39% |
| 2004-03-31 | $0.02B | $0.16B | 12.44% |
| 2003-12-31 | $0.02B | $0.16B | 14.81% |
| 2003-09-30 | $0.02B | $0.15B | 14.41% |
| 2003-06-30 | $0.02B | $0.15B | 14.69% |
| 2003-03-31 | $0.02B | $0.14B | 15.83% |
| 2002-12-31 | $0.02B | $0.15B | 14.95% |
| 2002-09-30 | $0.02B | $0.14B | 15.29% |
| 2002-06-30 | $0.02B | $0.13B | 15.69% |
| 2002-03-31 | $0.02B | $0.12B | 16.11% |
| 2001-12-31 | $0.02B | $0.11B | 16.54% |
| 2001-09-30 | $0.02B | $0.10B | 16.53% |
| 2001-06-30 | $0.01B | $0.09B | 16.28% |
| 2001-03-31 | $0.01B | $0.09B | 15.90% |
| 2000-12-31 | $0.01B | $0.08B | 15.38% |
| 2000-09-30 | $0.01B | $0.08B | 14.81% |
| 2000-06-30 | $0.01B | $0.08B | 15.44% |
| 2000-03-31 | $0.01B | $0.07B | 14.71% |
| 1999-12-31 | $0.01B | $0.07B | 13.79% |
| 1999-09-30 | $0.01B | $0.07B | 12.75% |
| 1999-06-30 | $0.01B | $0.06B | 13.33% |
| 1999-03-31 | $0.01B | $0.06B | 13.85% |
| 1998-12-31 | $0.01B | $0.06B | 14.55% |
| 1998-09-30 | $0.01B | $0.06B | 15.24% |
| 1998-06-30 | $0.01B | $0.06B | 14.00% |
| 1998-03-31 | $0.01B | $0.05B | 12.63% |
| 1997-12-31 | $0.01B | $0.05B | 10.75% |
| 1997-09-30 | $0.00B | $0.05B | 9.25% |
| 1997-06-30 | $0.00B | $0.05B | 8.99% |
| 1997-03-31 | $0.00B | $0.05B | 8.74% |
| 1996-12-31 | $0.01B | $0.04B | 14.71% |
| 1996-09-30 | $0.01B | $0.05B | 16.33% |
| 1996-06-30 | $0.01B | $0.05B | 17.14% |
| 1996-03-31 | $0.01B | 20.51% | |
| 1995-12-31 | $0.01B | $0.05B | 13.99% |
| 1995-09-30 | $0.00B | $0.04B | 13.11% |
| 1995-06-30 | $0.00B | $0.03B | 11.76% |
| 1995-03-31 | $0.00B | $0.03B | 12.12% |
| 1994-12-31 | $0.00B | $0.03B | 12.50% |
| 1994-09-30 | $0.00B | $0.02B | 13.04% |
| 1994-06-30 | $0.00B | $0.02B | 13.64% |
| 1994-03-31 | $0.00B | $0.02B | 14.46% |
| 1993-12-31 | $0.00B | $0.02B | 15.19% |
| 1993-09-30 | $0.00B | $0.02B | 15.79% |
| 1993-06-30 | $0.00B | $0.02B | 22.22% |
| 1993-03-31 | $0.00B | $0.02B | 23.53% |
| 1992-12-31 | $0.01B | $0.02B | 37.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.777B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.959B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $150.458B | 0.00 |
| Boston Scientific (BSX) | United States | $144.746B | 33.10 |
| Stryker (SYK) | United States | $140.556B | 27.91 |
| Medtronic (MDT) | Ireland | $125.035B | 17.32 |
| Medline (MDLN) | United States | $53.232B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.704B | 0.00 |
| Agilent Technologies (A) | United States | $42.105B | 26.62 |
| GE HealthCare Technologies (GEHC) | United States | $39.758B | 19.01 |
| ResMed (RMD) | United States | $36.846B | 25.50 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $21.735B | 24.47 |
| Insulet (PODD) | United States | $20.333B | 63.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.401B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.263B | 0.00 |
| Baxter (BAX) | United States | $10.831B | 8.74 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.735B | 31.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.480B | 13.65 |
| BillionToOne (BLLN) | United States | $3.933B | 0.00 |
| Envista Holdings (NVST) | United States | $3.885B | 22.29 |
| Haemonetics (HAE) | United States | $3.840B | 17.09 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.086B | 14.07 |
| QuidelOrtho (QDEL) | United States | $2.286B | 14.69 |
| Neogen (NEOG) | United States | $2.093B | 45.81 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.928B | 38.81 |
| Curaleaf Holdings (CURLF) | Canada | $1.716B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.680B | 73.64 |
| Phibro Animal Health (PAHC) | United States | $1.599B | 15.97 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.577B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.425B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| BioLife Solutions (BLFS) | United States | $1.197B | 355.14 |
| Capricor Therapeutics (CAPR) | United States | $1.090B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.031B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.005B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Omeros (OMER) | United States | $0.886B | 0.00 |
| CeriBell (CBLL) | United States | $0.865B | 0.00 |
| Valneva SE (VALN) | France | $0.850B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.563B | 15.26 |
| Verano Holdings (VRNO) | United States | $0.461B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| Brainsway (BWAY) | Israel | $0.453B | 77.03 |
| Cresco Labs (CRLBF) | United States | $0.443B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.396B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Evolus (EOLS) | United States | $0.366B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.290B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 21.94 |
| Sanuwave Health (SNWV) | United States | $0.266B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| High Tide (HITI) | Canada | $0.234B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Vireo Growth (VREOF) | United States | $0.208B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Accendra Health (ACH) | United States | $0.190B | 1.91 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Apyx Medical (APYX) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| MacroGenics (MGNX) | United States | $0.116B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.71 |
| ImmuCell (ICCC) | United States | $0.059B | 24.98 |
| Sharps Technology (STSS) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.051B | 37.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.53 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |